Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Denosumab (Prolia) 60 Mg/ml Subcutaneous Solution 1 Ml[mort] (CDM 109866884) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 26, 2026 , from http://ppman.hank.ai/transparency/procedure/109866884/by-state?code_type=CDM
“Denosumab (Prolia) 60 Mg/ml Subcutaneous Solution 1 Ml[mort] (CDM 109866884) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/109866884/by-state?code_type=CDM. Accessed
October 26, 2026 .
“Denosumab (Prolia) 60 Mg/ml Subcutaneous Solution 1 Ml[mort] (CDM 109866884) by State,” HANK Price Transparency ,
accessed October 26, 2026 ,
http://ppman.hank.ai/transparency/procedure/109866884/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
109866884 — Denosumab (Prolia) 60 Mg/ml Subcutaneous Solution 1 Ml[mort]
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$5,948
National median
$4,806 – $6,189
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 109866884 (CDM), with interquartile range
State Median p25 p75
KS $5,948 $4,806 $6,189